Pancreatic Cancer Research

ResearcherOkayama UniversityActive in the last 2 years

Kazuya Yasui

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5101121184. Sources: OpenAlex.

Their work

Papers
14
Trials
0
Grants
0
Labs led
0
Collaborators
27
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 3 papers · 2025: 5 papers · 2026: 3 papers

Papers 14

  1. Clinical Significance of a Cell-Of-Origin-Based Classification in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1111/cas.70533↗
  2. Impact of Cirrhosis Outcome Risk Estimator Score on Outcomes Following Pancreatectomy for Resectable Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.21873/invivo.14364↗
  3. Predictive Nomogram for Recurrence After Upfront Surgery for Resectable Pancreatic Ductal Adenocarcinoma: A Multicenter Study (OS-HBP-2). Co-author DOI 10.3390/cancers18071181↗
  4. Robotic posterior radical antegrade modular pancreatosplenectomy for left-sided pancreatic cancer using the ligament of Treitz first approach: A case report an… Co-author DOI 10.1016/j.ijscr.2025.111782↗
  5. Gemcitabine-induced neutrophil extracellular traps via interleukin-8-CXCR1/2 pathway promote chemoresistance in pancreatic cancer. Co-author DOI 10.1038/s41416-025-03192-1↗
  6. Precise stratification of prognosis in pancreatic ductal adenocarcinoma patients based on pre- and postoperative genomic information. Co-author DOI 10.1186/s12935-025-03894-9↗
  7. Impact of Neoadjuvant Chemotherapy with Gemcitabine Plus S-1 in Patients with Resectable Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers17203287↗
  8. Prognosis Prediction Model After Upfront Surgery for Resectable Pancreatic Ductal Adenocarcinoma: A Multicenter Study (OS-HBP-2). Co-author DOI 10.3390/cancers17223694↗
  9. Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic adenovirus. Co-author DOI 10.1038/s41416-024-02583-0↗
  10. Author Correction: Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic adenovirus. Co-author DOI 10.1038/s41416-024-02850-0↗
  11. Robot-Assisted Pancreaticoduodenectomy Using the Anterior Superior Mesenteric Artery-First Approach for Pancreatic Cancer. Co-author DOI 10.1245/s10434-024-16305-6↗
  12. Role of Surgery for Pancreatic Ductal Adenocarcinoma in the Era of Multidisciplinary Treatment. Co-author DOI 10.3390/jcm12020465↗
  13. Feasibility of local therapy for recurrent pancreatic cancer. Co-author DOI 10.1016/j.pan.2022.05.004↗
  14. Usefulness of Middle Colic Artery Transposition Technique for Hepatic Arterial Reconstruction in Conversion Surgery for an Initially Unresectable, Locally Adva… Co-author DOI 10.18926/amo/62410↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Toshiyoshi Fujiwara · 13 shared papers, 2021–2026 · strength 2.84
  2. Kosei Takagi · 12 shared papers, 2021–2026 · strength 2.73
  3. Ryuichi Yoshida · 8 shared papers, 2021–2026 · strength 1.47
  4. Takeyoshi Nishiyama · 4 shared papers, 2024–2026 · strength 1.02
  5. Kazuyuki Matsumoto · 3 shared papers, 2025 · strength 0.77
  6. Yuzo Umeda · 4 shared papers, 2021–2025 · strength 0.67
  7. Yasuo Nagai · 3 shared papers, 2024–2025 · strength 0.66
  8. Yuki Fujii · 3 shared papers, 2025–2026 · strength 0.66
  9. Motoyuki Otsuka · 3 shared papers, 2025–2026 · strength 0.66
  10. Shinji Kuroda · 3 shared papers, 2024–2025 · strength 0.54
  11. Shigeru Horiguchi · 2 shared papers, 2025–2026 · strength 0.47
  12. Takehiro Okabayashi · 2 shared papers, 2025–2026 · strength 0.46
  13. Kenta Sui · 2 shared papers, 2025–2026 · strength 0.46
  14. Masashi Hashimoto · 2 shared papers, 2024 · strength 0.33
  15. Kazuhiro Yoshida · 2 shared papers, 2021–2022 · strength 0.28
  16. Soichiro Ako · 1 shared paper, 2026 · strength 0.22
  17. Koichiro Tsutsumi · 1 shared paper, 2026 · strength 0.22
  18. Daisuke Uchida · 1 shared paper, 2026 · strength 0.22
  19. Tatsuya Kikuchi · 1 shared paper, 2026 · strength 0.22
  20. Hiroyuki Terasawa · 1 shared paper, 2026 · strength 0.22
  21. Hideaki Kinugasa · 1 shared paper, 2026 · strength 0.22
  22. Tomohiko Yagi · 1 shared paper, 2025 · strength 0.21
  23. Shohei Nogi · 1 shared paper, 2025 · strength 0.21
  24. Kokichi Miyamoto · 1 shared paper, 2025 · strength 0.19
  25. Hironari Kato · 1 shared paper, 2025 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.